Quinine

Overview

Categories

Primary Characterstics

Indications

Quinine is primarily indicated in conditions like Acute leukemia, Adjunctive therapy without valproate, Chloroquine resistant malaria, Lymphomas, Muscle spasm in myotonia congenita, Nocturnal muscle cramps prevention, Severe falciparum malaria.

Back to top

Pharmacokinetics

Back to top

Contraindications

Back to top

Drug Interactions

Back to top

Side Effects

Back to top

Dosage

Silymarin's dosage details are as follows:
Dose Single Dose Frequency Route Instructions

Adult Dosage
10 mg/ kg10 (10)8 hourlyPO,IM,IV InfFor 7 days.

Paedriatic Dosage (20kg)
10 mg/kg10 (10)8 hourlyOralFor 7 Days (As Quinine Sulphate)

Neonatal Dosage (3kg)
10 mg/kg10 (10)8 hourlyOralFor 7 Days (As Quinine Sulphate)

High Risk Groups

Back to top

Warning / Precautions

Back to top

Storage Conditions

Back to top

Interference in Pathology

  • Methods for Measuring Urinary Alkaloids, Corticosteroids, 17-OH-Corticosteroids & Heroin
  • False Decrease in ESR
  • Tests for Plasma Catecholamines

Back to top

Brands / Trade Names of Silymarin

Back to top

Previous Drug Generic - Next Drug Generic


Suggested Pages